PUTRAJAYA: Malaysia has granted conditional approval to more Covid-19 vaccines to be used in the country.
Health director-general Tan Sri Dr Noor Hisham Abdullah said the Drug Control Authority met on Tuesday (March 2) and approved conditional registration for the vaccines produced by Britain's AstraZeneca and China’s Sinovac.
The authority also gave additional approval to Pfizer-BioNTech, which produces the "Comirnaty" vaccine, for its vaccines that are manufactured in Mainz, Germany.
The vaccine approved earlier was manufactured in Puurs, Belgium. It is the type used to vaccinate the country’s frontliners when the National Covid-19 Immunisation Programme kicked off on Feb 26.
“This conditional registration requires the holding company to submit analysis of the latest data by rolling submission, that will be evaluated by the National Pharmaceutical Regulatory Division (NPRA).
“This is to ensure that the effectiveness and safety of the vaccine is always updated and the 'benefits over risk' of each vaccine remains positive, ” said Dr Noor Hisham at his Covid-19 updates press conference here on Tuesday (March 2).
Dr Noor Hisham added that the NPRA is still evaluating two other Covid-19 vaccines, including the Russian-made Sputnik V.